Stock research log
$LLY Insider Trading
Eli Lilly and Company
22
Alerts Listed
0
Insider Buys 30d
0
Insider Sells 30d
This page is InsiderWatch’s research log for LLY: the alerts we sent on this stock, timestamped, plus recent insider buying and selling reported to the SEC on Form 4.
Price and Our Alerts
$LLY price
Daily closing prices
3M change
+9.9%
1Y high
$1,418
1Y low
$851.21
Our alerts
22
in this window
Prices from public market data and may be delayed. Markers show the days our alerts on this stock fired. Not investment advice.
Our Alerts on $LLY
| Sent (ET) | Call | Alert |
|---|---|---|
| Oct 29, 7:01 AM | NEUTRAL | Eli Lilly raises full-year guidance after third quarter |
| Oct 28, 7:00 AM | BULLISH | Lilly's retatrutide beats Ozempic in head-to-head Phase 3 |
| Oct 2, 6:55 PM | NEUTRAL | Lilly's Foundayo beats expectations in late-stage diabetes study |
| Sep 30, 8:20 AM | NEUTRAL | Lilly's EBGLYSS hits goals in hand-foot eczema study |
| Sep 29, 2:46 AM | NEUTRAL | Lilly wins Onswik insulin, alopecia label approvals |
| Sep 27, 4:51 PM | NEUTRAL | Medicare obesity coverage boosts Lilly GLP-1 uptake |
| Sep 25, 11:57 AM | NEUTRAL | Nektar wins $90M jury verdict against Eli Lilly |
| Sep 24, 6:51 AM | BULLISH | FDA approves Lilly's once-weekly insulin Onswik |
| Sep 22, 6:35 PM | NEUTRAL | Eli Lilly CEO reveals astonishing shift in GLP-1 pill market |
| Sep 21, 1:01 PM | NEUTRAL | Lilly CEO touts fast Foundayo pill uptake |
| Sep 18, 2:02 PM | BULLISH | FDA approves Lilly's Inluriyo for advanced breast cancer |
| Sep 15, 11:05 AM | NEUTRAL | Lilly's oral obesity pill gains share fast |
| Sep 11, 5:19 PM | BEARISH | Morgan Stanley cuts Novo Nordisk to Sell |
| Sep 8, 1:04 AM | BEARISH | Novartis Lp(a) drug fails, clouding rival cholesterol programs |
| Sep 4, 9:08 PM | NEUTRAL | Lilly launches oral weight-loss pill Foundayo in UK |
| Sep 1, 10:56 AM | NEUTRAL | FDA move gives Eli Lilly GLP-1 payer edge |
| Aug 31, 12:42 PM | NEUTRAL | Eli Lilly strikes $2.9 billion Merida acquisition |
| Aug 30, 10:50 AM | NEUTRAL | Eli Lilly wins Mounjaro cardiovascular risk label expansion |
| Aug 28, 1:14 PM | NEUTRAL | Mounjaro wins FDA heart-risk label expansion |
| Aug 27, 10:54 AM | NEUTRAL | FDA clears Lilly-Roche Alzheimer's blood test |
| Aug 24, 3:26 AM | NEUTRAL | Eli Lilly launches oral weight-loss pill in UK |
| Aug 22, 12:41 AM | NEUTRAL | Eli Lilly up 6% on UK Foundayo approval |
Every alert we sent on LLY is listed after a short delay, in the order it went out. The call shown is the one in the alert as sent.
Congress Trading in $LLY
Members of Congress who disclosed trades in LLY under the STOCK Act since we began tracking. Each name links to that member’s full page. Amounts are the disclosed ranges (see how the ranges work) and filings can arrive up to 45 days after the trade.
| Member | Action | Amount |
|---|---|---|
| Gilbert CisnerosHouse | BUY | $50,001 - $100,000 |
| Byron DonaldsHouse | BUY | $1,001 - $15,000 |
| Byron DonaldsHouse | BUY | $1,001 - $15,000 |
| Gilbert CisnerosHouse | BUY | $1,001 - $15,000 |
| Elizabeth FletcherHouse | SELL | $1,001 - $15,000 |
| Gilbert CisnerosHouse | SELL | $1,001 - $15,000 |
| David J. TaylorHouse | BUY | $1,001 - $15,000 |
| David J. TaylorHouse | SELL | $1,001 - $15,000 |
| David J. TaylorHouse | SELL | $1,001 - $15,000 |
| Julie JohnsonHouse | SELL | $1,001 - $15,000 |
Disclosed amounts are ranges. Filing and trade dates, who in the household traded, and full histories are part of the subscriber dashboard.
See the research log across all stocks, this week’s insider buying, or the congress trading tracker.
Get the Next LLY Alert When It Fires.
Everything here is already public. Subscribers usually got it within minutes. Pro members get every alert. Free for 7 days, cancel any time.
Try Free for 7 DaysInsiderWatch is an informational research service based on publicly available information only and is not financial, investment, legal, or tax advice. The call shown is a reading of the event, not a recommendation to trade.